Reviewing your Assessment output

Once a drug assessment has completed, the output is organized by domains and subdomains, each representing a distinct area of analysis. This article walks you through how to navigate the domain detail view and make use of the evidence, risk, and parameter information it contains.

Opening a domain

From the Drug Assessment tab, click on any domain name to open its detail view. Each domain follows the same structure, making it easy to navigate across different areas of the assessment consistently.

The domain detail view is organized into three main sections: Summary, Risk, and Assessment Details. Each are described in detail below.

Section 1: Summary

The summary section provides a high-level view of the domain findings. It includes an overall assessment of the domain, including a summary of key findings and identified risks. This is the right place to start when getting oriented to a domain before diving into the detail.

Section 2: Risk category by Subdomain

This section breaks down risk across the subdomains that apply to the domain. Each subdomain is listed in the left navigation: click a category to view its full assessment detail in the main panel.

Modifying risk levels. Authorized users can adjust the risk level assigned to any category. This may be appropriate when your team's expert judgment differs from the model's initial assessment, or when new context has emerged through diligence. All changes to risk levels are auditable: the record of who changed what, and when, is preserved in the change log.

Note that risk level modifications should reflect a considered review by the appropriate domain expert. Changes are recorded and visible to all authorized users on the assessment.

Section 3: Assessment details

The assessment details section provides the supporting material behind each risk category's findings. It is organized into four tabs

Evidence. The source references that informed the assessment findings for this risk category. Click any reference to jump directly to the relevant article and the specific section where the information was cited.
Impacted Parameters. The valuation parameters that may warrant adjustment in light of the domain findings. Baseline and benchmark values are displayed for context.
Change log. A full record of all parameter adjustments made within this domain, including the date of the change, the user who made it, and any notes added at the time.
Questions and Answers. The underlying question set that powers Prudentia's assessment model for this domain. These are the structured questions the model interrogates against your data to produce its findings; reviewing them gives your team transparency into how the assessment was constructed and what the model was evaluating.

Working with Impacted Parameters

Impacted Parameters are the connection between the clinical and scientific findings in Prism and the financial modeling in Valuation & Risk Simulation.

When you open the Impacted Parameters tab for a risk category, you will see:

Baseline value. The default parameter value used as the starting point for the valuation model.

Benchmark value
Benchmark value. A reference value drawn from comparable assets or industry data, provided for context.
Delta value. An adjustment you can enter based on your team's expert review of the domain finding
Final value. The adjusted value that will be applied in the Valuation & Risk Simulation. This reflects the baseline plus any delta entered by your team.

Note that parameter adjustments flow directly into the Valuation & Risk Simulation. Consult with the appropriate domain expert before entering a delta value, and use the Notes field to document the rationale. This will be captured in the change log for audit purposes.